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Abstract
Background: Targets for intervention are required for respiratory syncytial virus (RSV) bronchiolitis, a common disease
during infancy for which no effective treatment exists. Clinical and genetic studies indicate that IL1RL1 plays an important
role in the development and exacerbations of asthma. Human IL1RL1 encodes three isoforms, including soluble IL1RL1-a,
that can influence IL33 signalling by modifying inflammatory responses to epithelial damage. We hypothesized that IL1RL1
gene variants and soluble IL1RL1-a are associated with severe RSV bronchiolitis.
Methodology/Principal Findings: We studied the association between RSV and 3 selected IL1RL1 single-nucleotide
polymorphisms rs1921622, rs11685480 or rs1420101 in 81 ventilated and 384 non-ventilated children under 1 year of age
hospitalized with primary RSV bronchiolitis in comparison to 930 healthy controls. Severe RSV infection was defined by need
for mechanical ventilation. Furthermore, we examined soluble IL1RL1-a concentration in nasopharyngeal aspirates from
children hospitalized with primary RSV bronchiolitis. An association between SNP rs1921622 and disease severity was found
at the allele and genotype level (p=0.011 and p=0.040, respectively). In hospitalized non-ventilated patients, RSV
bronchiolitis was not associated with IL1RL1 genotypes. Median concentrations of soluble IL1RL1-a in nasopharyngeal
aspirates were .20-fold higher in ventilated infants when compared to non-ventilated infants with RSV (median [and
quartiles] 9,357 [936–15,528] pg/ml vs. 405 [112–1,193] pg/ml respectively; p,0.001).
Conclusions: We found a genetic link between rs1921622 IL1RL1 polymorphism and disease severity in RSV bronchiolitis.
The potential biological role of IL1RL1 in the pathogenesis of severe RSV bronchiolitis was further supported by high local
concentrations of IL1RL1 in children with most severe disease. We speculate that IL1RL1a modifies epithelial damage
mediated inflammatory responses during RSV bronchiolitis and thus may serve as a novel target for intervention to control
disease severity.
Citation: Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, et al. (2012) IL1RL1 Gene Variants and Nasopharyngeal IL1RL-a Levels Are Associated with
Severe RSV Bronchiolitis: A Multicenter Cohort Study. PLoS ONE 7(5): e34364. doi:10.1371/journal.pone.0034364
Editor: Malcolm Gracie Semple, University of Liverpool, United Kingdom
Received October 6, 2011; Accepted February 27, 2012; Published May 4, 2012
Copyright:  2012 Faber et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: GK from the University Medical Center Groningen, GRIAC Research Institute, was supported by the Netherlands Asthma Foundation, grant
3.2.09.081JU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tina.faber@gmail.com
Introduction
Respiratory syncytial virus (RSV) bronchiolitis is the most
common cause of hospitalization for infants during the winter
season. About 1–2% of all children are hospitalized for RSV
bronchiolitis, mechanical ventilation is required in 10% of
hospitalized cases [1]. Approximately half of the infants with
RSV lower respiratory tract infection (LRTI) go on to have
recurrent wheezing episodes until they reach school age [2–4].
The overall risk of concurrent bacterial infection is low, yet the
reported incidence of bacterial pneumonia in children with severe
RSV infection requiring ventilation ranges from 9%–44% [5–13].
Mechanisms underlying severe respiratory syncytial virus bron-
chiolitis are incompletely understood.
There is increasing evidence, from both clinical and genetic
studies, that IL1RL1 plays an important role in the development of
childhood asthma [14–18]. IL1RL1 gene cluster polymorphisms
were found to be associated with asthma and atopy [14,15,18].
Human IL1RL1 encodes the receptor for interleukin-33 (IL33) and
has three isoforms, including soluble IL1RL1 (IL1RL1-a), that can
modify T helper cell responses by inhibition of IL33 signalling
[17,19–23]. IL1RL1-a can be induced by pro-inflammatory
stimuli and appears to be essential for the normal function of T
helper cells [20–22]. Clinically, IL1RL1 genetic polymorphisms
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e34364and IL1RL1-a serum levels have been associated with severe
arthritis, acute heart disease, and airway disease such as asthma
[24–28].
Methods
Ethics Statement
The study protocol was approved by the institutional review
board ‘‘RTPO’’ at the Medical Center Leeuwarden in and the
medical ethics committee ‘‘METC’’ at the University Medical
Center Utrecht in The Netherlands. All parents of hospitalized
infants agreed to participate and gave written informed consent.
Objectives
We hypothesized that IL1RL1 plays a role in the pathogenesis of
severe RSV bronchiolitis. To this end, we analyzed IL1RL1 single-
nucleotide polymorphisms (SNPs) for association with RSV
disease. Furthermore, we examined the association between local
IL1RL1-a concentrations and RSV disease severity.
Participants
In a multicenter cohort study, previously healthy infants under 1
year of age hospitalized with a first episode of RSV bronchiolitis
were included from October 2007 until March 2009 in fifteen
large urban hospitals in The Netherlands. Infants with Down
syndrome, a history of wheezing, or cardiac or pulmonary
pathology were excluded. RSV infection was confirmed by
positive immunofluorescence in epithelial cells from nasopharyn-
geal aspirates (NPAs) as described previously [29,30]. Severity of
RSV illness was distinguished by need for mechanical ventilation,
apparent by intubation and admission to a Pediatric Intensive
Care Unit (PICU). Indication for mechanical ventilation in all
centers was: severe respiratory distress or exhaustion, apnea’s,
respiratory acidosis (pH,7.25), or hypoxia (oxygen saturation
,92% despite oxygen therapy). For the genetic cohort study, only
children of Dutch ethnicity were selected. The control population
consisted of 930 healthy Dutch children that were randomly taken
from the Regenboog study, a large Dutch population health
examination survey [31]. In a subgroup of hospitalized patients
(n=207) with primary RSV disease, IL1RL1-a concentrations on
the day of admission were measured in NPAs.
Investigations
Three SNPs were chosen on the basis of their potential
functionality or their association with asthma in previous
association studies [14,15,18,32,33]. For each SNP 1.5 mlo f
genomic DNA was used at 7 ng/ml. SNPs rs1921622, rs11685480
and rs1420101 present in intronic and 59near-gene regions of the
IL1RL1 were selected for genotyping by SNP Genotyping Services
at KBioscience (Hoddesdon, United Kingdom) with the KASPar
technology and compared to healthy controls in the population.
IL1RL1-a concentrations on the day of admission were measured
in NPAs using ELISA (R&D systems, Abingdon, United King-
dom).
Statistical Methods
For the genetic study, a convenient genetic cohort of 465
patients and 930 controls was used. Because IL1RL1 SNPs were
specifically tested, no multiple testing was required. Genotyping
data were viewed graphically as a scatter plot with SNPviewer2.
All SNPs were analyzed for association with RSV disease, both at
the allele level (df=1) and at the genotype level (df=2) by
Kruskal-Wallis test. Furthermore, a subanalysis was performed for
association between SNPs and severe RSV disease characterized
by need for mechanical ventilation. Association between IL1RL1-
a concentration and RSV genotype was examined by Kruskal-
Wallis test. The clinical study including 20 ventilated and 187 non-
ventilated patients was designed to detect an arbitrarily chosen
difference in IL1RL1-a concentrations of 180 pg/ml with a
standard deviation of 200 and a power and significance of 0.8 and
0.05 respectively for a two-sided test. Mann-Whitney U test was
used to compare IL1RL1-a concentrations on the day of
admission in non-ventilated versus ventilated infants. All tests of
significance were two-sided. P-values ,0.05 were considered to be
statistically significant.
Results
In the genetic cohort study, a total of 465 Dutch children from
0–12 months of age hospitalized with primary RSV bronchiolitis
were included and compared to 930 healthy Dutch controls in
the population. Polymorphisms tested were in Hardy-Weinberg
equilibrium. RSV bronchiolitis was not associated with selected
genotypes rs1921622, rs11685480 or rs1420101 (p.0.05, table 1).
Table 1. IL1RL1 SNPs not associated with RSV bronchiolitis.
refSNP ID RSV hospitalized infants
1 (n=465) Population controls
1 (n=930) Missing values P-value
2
Allele AG A G
rs1921622 498 422 1002 826 42 0.734
rs11685480 468 454 925 915 28 0.809
rs1420101 343 571 706 1130 40 0.638
Genotype AA GA GG AA GA GG
rs1921622 138 222 100 287 428 199 42 0.849
rs11685480 117 234 110 219 487 214 28 0.727
rs1420101 62 219 176 129 448 341 40 0.882
IL1RL1 selected genotypes rs1921622, rs11685480 and rs1420101 are not associated with RSV bronchiolitis in hospitalized infants when compared to healthy controls in
the population.
RefSNP ID is the Reference SNP (rs) Number; SNP, single-nucleotide polymorphism.
1Number of alleles and genotypes.
2According to x
2 distribution of a 262 table on allele or genotype frequencies.
3Reference allele is the major allele.
doi:10.1371/journal.pone.0034364.t001
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between disease severity for the IL1RL1 SNP rs1921622 at the
allele level (p=0.011) and the genotype level (p=0.04) (table 2).
We further investigated our genetic finding of a potential role of
IL1RL1 in severe RSV bronchiolitis by analyzing the relationship
between local IL1RL1-a concentration and disease severity. In 207
hospitalized infants with RSV bronchiolitis, 20 ventilated and 187
non-ventilated, NPA was available to measure local IL1RL1-a
levels. As expected, gestational age was lower, and length of
hospital stay was longer, in children requiring mechanical
ventilation (38.7 weeks vs. 39.7 weeks, p=0.032; 14 days vs. 4
days, p,0.001). All other variables, such as age at admission, male
gender, breastfeeding, older siblings, smoking in the household or
during pregnancy, born during RSV season, daycare attendance
and atopy did not differ between groups. (table 3) Median
concentrations of IL1RL1-a in nasopharyngeal aspirates were
.20-fold higher in ventilated infants when compared to non-
ventilated infants with RSV (median [and quartiles] 9,357 [936–
15,528] pg/ml vs. 405 [112–1,193] pg/ml respectively; p,0.001,
figure 1). Regression analysis showed that this effect was
independent from gestational age. IL1RL1-a concentrations were
not associated with any of the 3 IL1RL1 SNPs. 3/20 (15%) of
ventilated patients had evidence of concurrent bacterial pneumo-
nia by definition of a positive bacterial culture on tracheal aspirate
with single growth .100 per visual field on the day of intubation
(2 patients with Haemophilus influenzae and 1 patient with Moraxella
catarrhalis).
Discussion
This study shows an association between the intron SNP
rs1921622 and severe RSV disease requiring mechanical ventila-
tion. The association between local IL1RL1-a levels and disease
severity found in this study, warrants speculation on a potential
role of IL1RL1 in modifying RSV disease severity. IL1RL1 is a
member of the Toll-like receptor (TLR) superfamily and can affect
Th2 responses by influencing Toll-like receptor pathway signal-
ling. [23,34–36]. IL1RL1 is located on chromosome 2q12. IL1RL1
translation results in 3 isoforms, of which IL1RL1-a is soluble [37].
The IL1RL1 gene encodes the receptor for interleukine (IL) 33,
and is located on mast cells, T helper type 2 (Th2) cells, regulatory
Table 2. IL1RL1 SNP rs1921622 associated with severe RSV bronchiolitis.
refSNP ID
RSV ventilated infants
1
(n=81)
RSV non-ventilated infants
1
(n=384)
Population controls
1
(n=930) Missing values P-value
2
Allele AG AG A G
rs1921622 73 89 425 333 10 0.011
rs1921622 73 89 1002 826 32 0.017
Genotype AA GA GG AA GA GG AA GA GG
rs1921622 17 39 25 121 183 75 287 428 199 5 0.040
Subgroup analysis showed an association between severe RSV disease characterized by need for mechanical ventilation and IL1RL1 SNP rs1921622 at both the allele
level, and at the genotype level (p=0.040).
RefSNP ID is the Reference SNP (rs) Number; SNP, single-nucleotide polymorphism.
1Number of alleles and genotypes.
2According to x
2 distribution of a 262 table on allele or genotype frequencies.
3
doi:10.1371/journal.pone.0034364.t002
Figure 1. Median concentrations of IL1RL1-a in nasopharyngeal aspirates of hospitalized infants with RSV were .20-fold higher in
mechanically ventilated infants at the Pediatric Intensive Care Unit (n=19) when compared to non-ventilated infants admitted to
the general pediatric ward (n=135) (median [and quartiles] 9,357 [936–15,528] pg/ml vs 405 [112–1,193] pg/ml respectively; Mann-
Whitney U test p,0.0001).
doi:10.1371/journal.pone.0034364.g001
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responses, such as IL4, IL5 and IL13, that induce eosinophilic
influx, airway inflammation, airway hyperresponsiveness, and
mucus production [23]. IL1RL1-a may act as a decoy receptor for
IL33 thus affecting the inflammatory response to epithelial
damage [17].
There is increasing evidence that IL1RL1 plays an important
role in the development of asthma. IL1RL1 gene cluster
polymorphisms and SNPs such as rs3771166, rs1420101 and
rs1041973 have been associated with childhood asthma [14–
18,32]. The results of this study suggest that IL1RL1 polymor-
phisms also play a role in affecting the severity of RSV disease.
This is not surprising considering the common pathophysiological
mechanisms of disease between asthma and RSV displayed by
airway inflammation, airway hyperresponsiveness and mucus
production as a result of epithelial damage.
Higher IL1RL1-a concentrations were found in children with
more severe disease requiring ventilation. This is consistent with
previous studies showing that higher IL1RL1-a serum concen-
trations were correlated with other clinically severe diseases such
as acute heart disease and asthma [24,26,27]. IL1RL1-a in
serum is also elevated in patients with acute pulmonary disease
and prognostic for death within one year [28]. The results of
the current study suggest that, in children with severe RSV
disease, IL1RL1-a inhibits IL33 signaling and thus affects the
endogenous ‘‘danger signal’’ that is normally stimulated by
epithelial damage. The role of IL1RL1-a in RSV disease has
not otherwise been studied in humans, but our findings are
supported by studies in RSV sensitized mice in which the
administration of anti-IL1RL1 antibodies resulted in attenuated
Th2-type cytokine-associated eosinophilic airway inflammation
[41].
A limitation of this part of the study is that the control group did
not include a group of non-RSV infected, hospitalized patients
affected by a different respiratory disease. Furthermore, there may
be potential confounders, such as secondary bacterial infection. In
general, rates of bacterial infection in hospitalized, febrile infants
with RSV bronchiolitis is low, but rates as high as 30–40% are
reported in ventilated patients [5–8,42]. In the 20 ventilated
infants in this study, only 3 (15%) had a positive bacterial culture
with single growth .100 per visual field on the day of intubation.
Haemophilus influenzae was found in 2 patients and Moraxella
catarrhalis was found in 1 patient.
Local IL1RL1-a concentration in RSV disease is not associated
with selected genotypes. Thus, although both RS 1921622 IL1RL1
polymorphisms and higher local IL1RL1-a concentrations are
associated with severe RSV disease, the suggestion of a gain-of-
function polymorphism could not be confirmed. These results are
similar to asthma studies in which associations between IL1RL1
genotypes and acute asthma or severe asthma could be demon-
strated, but not between serum IL1RL1-a and studied genotypes
[15]. In contrast, one recent study showed an association between
IL1RL1 polymorphisms and serum IL1RL1-a [32]. A recent large
scale genome-wide association study of asthma found associations
between asthma and SNP rs3771166 on chromosome 2 implicat-
ing a role for IL1RL1, but also variants at different loci associated
with different types of asthma, such as childhood asthma [17].
Intron 10 SNPs are in linkage disequilibrium with IL1RL1 and
IL18R1. Although we attribute the effect at this locus to IL1RL1,
as in previous studies [17], an IL18R1 effect cannot be excluded
since SNP rs1921622 is in linkage disequilibrium with SNPs in
IL18R1.
In conclusion, our data demonstrate for the first time a genetic
association between IL1RL1 and disease severity of RSV
bronchiolitis. High IL1RL1-a production in the airways of
children with severe RSV bronchiolitis suggests this molecule
plays a role in modifying the inflammatory response to epithelial
damage, as it does in severe asthma.
Table 3. Subject characteristics of infants hospitalized for RSV bronchiolitis with IL1RL1-a measured in nasopharyngeal aspirate.
Mechanically ventilated
infants (n=20)
Non-mechanically ventilated
infants (n=187) P-value
Male gender (n (%)) 16 (80%) 105 (56%) 0.055 #
Gestational age (median weeks (quartiles)) 38.7 (37.0–39.9) 39.7 (38.1–40.6) 0.032 *
Born during RSV season (n (%)) 17 (85%) 129 (70%) 0.197 #
Breastfeeding (n (%)) 12 (60%) 111 (60%) 1.000 #
One or more older siblings (n (%) 18 (90%) 146 (78%) 0.261 #
Daycare attendance $1 day per week (n (%)) 3 (15%) 48 (26%) 0.415 #
Atopy in the 1
st degree family (n (%)) 11 (55%) 129 (69%) 0.216 #
Smoking during pregnancy (n (%)) 6 (30%) 34 (18%) 0.233 #
Smoking in the household (n (%)) 3 (15%) 15 (8%) 0.392 #
Age at admission (median days (quartiles)) 70 (41–137) 51 (35–75) 0.094 *
Length of hospital stay (median days (quartiles)) 14 (12–19) 4 (2–6) ,0.001 *
Duration of ventilation (median days (quartiles)) 9 (7–15) n.a.
IL1RL1-a measured in nasopharyngeal aspirate (n (%)) 19 (95)u 135 (72)u
Genotyping for 3 selected IL1RL1 SNPs (n (%)) 10 (50)u 120 (64)u
#Fisher’s exact test.
*Mann-Whitney U test.
n.a.=not applicable.
Analyses were performed in nasopharyngeal aspirates of hospitalized, non-ventilated infants with respiratory syncytial virus (RSV) infection and ventilated infants at the
Pediatric Intensive Care Unit with RSV.
6Excluded samples of poor quality had too little material to perform genotyping or an IL1RL1-a measurement.
doi:10.1371/journal.pone.0034364.t003
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